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ditorialisiting  time  and  clinical  ﬁndings  on  admission  in  patients  with  acute  heart
ailure—Day  and  night,  why  is  it  so?Acute heart failure (AHF) can be deﬁned as new onset or grad-
al or rapidly worsening HF signs and symptoms requiring urgent
herapy [1].  Hospitalization for AHF is one of the most important
auses of in-hospital and post-discharge mortality and readmission
n patients with chronic HF [2].  AHF is characterized by several pre-
entations of signs and symptoms: pulmonary edema; peripheral
dema/congestion; cardiogenic shock; high blood pressure; and
ight HF. Because management at initial or early phase is critical for
he patients with AHF, evaluation of characteristics of the patients
n admission is important.
Matsushita et al. [3] demonstrate interesting data of associa-
ion between the visiting time and clinical ﬁndings on admission in
atients with AHF. Five hundred and thirty-one patients with AHF
ho were admitted to the intensive care unit (ICU) in the Chiba
okuso Hospital were retrospectively divided into two  groups:
aytime HF group (group D: admitted from 08:00 h to 20:00 h) and
ighttime HF group (group N: admitted from 20:00 h to 08:00 h).
he patients with AHF who needed to be treated in the ICU were
dmitted more frequently at night than during the daytime. The
atients in group N showed higher systolic blood pressure and heart
ate than those in group D. The patients complaining of orthopnea
ere more likely in group N than in group D. These observations
ere supported by multivariate regression model analysis. In a
omparison of the outcomes between groups, the length of ICU hos-
italization was shorter in group N than in group D, although the
ength of total hospitalization and in-hospital mortality were not
ifferent.
This article gives us two interesting insights into the relations
etween the time of admission, clinical manifestations, and in-
ospital outcomes. First is high prevalence in the patients with
HF in group N showing characteristics matched to clinical sce-
ario (CS)-1 more likely than those who were admitted during the
aytime. This evidence is supported by the objective data of higher
ystolic blood pressure and higher frequency of orthopnea in group
 than in group D. There is an important study that achieved the
ame aims as the present article. Minami et al. prospectively ana-
yzed the data of 2867 patients with AHF from all regions of Japan
n the ATTEND registry [4].  The ATTEND registry included patients
ith NYHA class II and had a different daytime admission time09:00 h to 17:59 h) from that of this study. The study protocol of
atsushita was single-centered and a retrospective analysis. The
aytime admission time is deﬁned as 08:00 h to 19:59 h. The num-
DOI of original article: http://dx.doi.org/10.1016/j.jjcc.2012.10.004.
914-5087/$ – see front matter © 2013 Japanese College of Cardiology. Published by Else
ttp://dx.doi.org/10.1016/j.jjcc.2013.02.004ber of study subjects is relatively small (n = 531). All the patients
were admitted to the ICU and showed severe exercise intolerance
(NYHA III or IV). Interestingly, these two  studies demonstrated sim-
ilar results although there are some important differences between
them in the study protocols. CS-1 was deﬁned for the patients
presenting with systolic blood pressure more than 140 mmHg, dys-
pnea due to pulmonary edema, but minimal systemic edema [5].
Vasodilators and/or non-invasive ventilation are recommended for
treatment of the patients with CS-1 and diuretics or inotropes
should be less likely to be used because of worsening prognosis in
patients with AHF [6,7]. Thus, the information of patients’ charac-
teristics may  be useful to decide therapeutic strategy. The authors
of this article speculated that the reason for high frequency of the
patients with CS-1 AHF at night is ﬂuid shift due to increase in
venous return by supine position. However, because sitting in the
upright position may  not always relieve this type of dyspnea [8],
decreased responsiveness of the respiratory center in the brain
[9] and decreased adrenergic activity in the myocardium during
sleep also contributes to pathophysiology of dyspnea due to AHF
at night. In addition to medical reasons, the environment in which
they live often has a signiﬁcant effect on how the patients per-
ceive their capabilities and their self-concepts [9].  Anxiety as well
as social isolation, loneliness and depression may  further decrease
functional performance and exaggerate symptoms such as dyspnea
at night.
The second interesting result is the in-hospital outcomes. There
was no difference in in-hospital mortality between patients in
group N and in group D in the present article. The data from
the ATTEND registry showed signiﬁcantly higher in-hospital all-
cause and cardiac death rates in the patients admitted in the
daytime compared with those admitted at nighttime in the uni-
variate analysis, however, there was no difference between groups
after adjusting covariates [4].  As shown above, the patients admit-
ted at night showed higher systolic blood pressure than those
admitted during daytime. Systolic blood pressure on admission
is an important predictor of in-hospital mortality and even post-
discharge mortality [10]. It correlates inversely with mortality; high
systolic blood pressure on admission is associated with a substan-
tially lower in-hospital and post-discharge mortality. Therefore, the
mortality rate of the patients admitted at night could be less than
that of during daytime. One speculation to explain no difference in
the mortality between groups is the inadequate medical care and
stafﬁng for the patients admitted at night. It is not an easy issue to
increase medical staff at nighttime, so we  should focus on ﬁnding
more effective treatment of AHF than ever.
vier Ltd. All rights reserved.
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